Clinical trial
Carboplatin in Patients With Progressive Gliomas
NCT00002749 · Duke University, Other · Completed
Key facts
| NCT number | NCT00002749 |
|---|---|
| Title | Carboplatin in Patients With Progressive Gliomas |
| Official title | PHASE II STUDY OF CARBOPLATIN (CBDCA) IN THE TREATMENT OF CHILDREN AND ADULTS WITH PROGRESSIVE LOW GRADE GLIOMAS |
| Lead sponsor | Duke University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | carboplatin |
| Enrollment | 25 |
| Start date | Feb 1, 1993 |
| Completion | Mar 1, 2000 |
| First posted | Aug 11, 2004 |
| Last update posted | Oct 14, 2009 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: